nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—DRD5—attention deficit hyperactivity disorder	0.164	0.212	CbGaD
Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.154	0.199	CbGaD
Quetiapine—DRD4—attention deficit hyperactivity disorder	0.0837	0.108	CbGaD
Quetiapine—HTR1B—attention deficit hyperactivity disorder	0.0744	0.0961	CbGaD
Quetiapine—DRD3—attention deficit hyperactivity disorder	0.0722	0.0933	CbGaD
Quetiapine—DRD1—attention deficit hyperactivity disorder	0.0709	0.0916	CbGaD
Quetiapine—ADRA2A—attention deficit hyperactivity disorder	0.0658	0.0851	CbGaD
Quetiapine—DRD2—attention deficit hyperactivity disorder	0.05	0.0646	CbGaD
Quetiapine—HTR2A—attention deficit hyperactivity disorder	0.0386	0.0499	CbGaD
Quetiapine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00382	0.0639	CbGeAlD
Quetiapine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00238	0.0398	CbGeAlD
Quetiapine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00203	0.034	CbGeAlD
Quetiapine—HTR1E—forebrain—attention deficit hyperactivity disorder	0.0013	0.0217	CbGeAlD
Quetiapine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00127	0.0212	CbGeAlD
Quetiapine—HTR6—forebrain—attention deficit hyperactivity disorder	0.00102	0.017	CbGeAlD
Quetiapine—DRD5—forebrain—attention deficit hyperactivity disorder	0.000991	0.0166	CbGeAlD
Quetiapine—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.000795	0.0133	CbGeAlD
Quetiapine—H1F0—forebrain—attention deficit hyperactivity disorder	0.000767	0.0128	CbGeAlD
Quetiapine—DRD1—forebrain—attention deficit hyperactivity disorder	0.000757	0.0127	CbGeAlD
Quetiapine—HTR3A—forebrain—attention deficit hyperactivity disorder	0.000731	0.0122	CbGeAlD
Quetiapine—HTR1E—nervous system—attention deficit hyperactivity disorder	0.000704	0.0118	CbGeAlD
Quetiapine—HTR1E—central nervous system—attention deficit hyperactivity disorder	0.000678	0.0113	CbGeAlD
Quetiapine—H1F0—cardiovascular system—attention deficit hyperactivity disorder	0.000648	0.0108	CbGeAlD
Quetiapine—DRD4—brain—attention deficit hyperactivity disorder	0.000624	0.0104	CbGeAlD
Quetiapine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.000617	0.0103	CbGeAlD
Quetiapine—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000613	0.0103	CbGeAlD
Quetiapine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00061	0.0102	CbGeAlD
Quetiapine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.000594	0.00994	CbGeAlD
Quetiapine—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000594	0.00993	CbGeAlD
Quetiapine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000588	0.00984	CbGeAlD
Quetiapine—DRD3—nervous system—attention deficit hyperactivity disorder	0.000574	0.0096	CbGeAlD
Quetiapine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.000555	0.00929	CbGeAlD
Quetiapine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000553	0.00924	CbGeAlD
Quetiapine—HTR6—nervous system—attention deficit hyperactivity disorder	0.000553	0.00924	CbGeAlD
Quetiapine—HTR1E—brain—attention deficit hyperactivity disorder	0.000538	0.009	CbGeAlD
Quetiapine—DRD5—nervous system—attention deficit hyperactivity disorder	0.000538	0.009	CbGeAlD
Quetiapine—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000532	0.0089	CbGeAlD
Quetiapine—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000519	0.00868	CbGeAlD
Quetiapine—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000518	0.00866	CbGeAlD
Quetiapine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000516	0.00863	CbGeAlD
Quetiapine—H1F0—midbrain—attention deficit hyperactivity disorder	0.000506	0.00847	CbGeAlD
Quetiapine—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000502	0.0084	CbGeAlD
Quetiapine—DRD1—midbrain—attention deficit hyperactivity disorder	0.0005	0.00836	CbGeAlD
Quetiapine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.000497	0.00831	CbGeAlD
Quetiapine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000495	0.00828	CbGeAlD
Quetiapine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.000483	0.00807	CbGeAlD
Quetiapine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000473	0.00791	CbGeAlD
Quetiapine—CHRM4—brain—attention deficit hyperactivity disorder	0.000472	0.00789	CbGeAlD
Quetiapine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00047	0.00785	CbGeAlD
Quetiapine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000465	0.00777	CbGeAlD
Quetiapine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000456	0.00763	CbGeAlD
Quetiapine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000447	0.00748	CbGeAlD
Quetiapine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000441	0.00737	CbGeAlD
Quetiapine—DRD3—brain—attention deficit hyperactivity disorder	0.000439	0.00734	CbGeAlD
Quetiapine—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000431	0.00721	CbGeAlD
Quetiapine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000425	0.0071	CbGeAlD
Quetiapine—HTR6—brain—attention deficit hyperactivity disorder	0.000422	0.00706	CbGeAlD
Quetiapine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000419	0.007	CbGeAlD
Quetiapine—H1F0—nervous system—attention deficit hyperactivity disorder	0.000416	0.00696	CbGeAlD
Quetiapine—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000415	0.00694	CbGeAlD
Quetiapine—DRD5—brain—attention deficit hyperactivity disorder	0.000411	0.00688	CbGeAlD
Quetiapine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000411	0.00687	CbGeAlD
Quetiapine—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000405	0.00677	CbGeAlD
Quetiapine—H1F0—central nervous system—attention deficit hyperactivity disorder	0.000401	0.0067	CbGeAlD
Quetiapine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.0004	0.00669	CbGeAlD
Quetiapine—HTR3A—nervous system—attention deficit hyperactivity disorder	0.000397	0.00664	CbGeAlD
Quetiapine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000396	0.00662	CbGeAlD
Quetiapine—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000392	0.00656	CbGeAlD
Quetiapine—H1F0—cerebellum—attention deficit hyperactivity disorder	0.000392	0.00655	CbGeAlD
Quetiapine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000388	0.0065	CbGeAlD
Quetiapine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000386	0.00645	CbGeAlD
Quetiapine—HTR3A—central nervous system—attention deficit hyperactivity disorder	0.000382	0.00639	CbGeAlD
Quetiapine—CHRM5—brain—attention deficit hyperactivity disorder	0.000369	0.00617	CbGeAlD
Quetiapine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000353	0.00591	CbGeAlD
Quetiapine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000347	0.0058	CbGeAlD
Quetiapine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000337	0.00564	CbGeAlD
Quetiapine—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000333	0.00557	CbGeAlD
Quetiapine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000331	0.00554	CbGeAlD
Quetiapine—ADRA1D—brain—attention deficit hyperactivity disorder	0.00033	0.00551	CbGeAlD
Quetiapine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000327	0.00547	CbGeAlD
Quetiapine—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000322	0.00539	CbGeAlD
Quetiapine—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000321	0.00536	CbGeAlD
Quetiapine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000319	0.00534	CbGeAlD
Quetiapine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000319	0.00533	CbGeAlD
Quetiapine—H1F0—brain—attention deficit hyperactivity disorder	0.000318	0.00532	CbGeAlD
Quetiapine—DRD1—brain—attention deficit hyperactivity disorder	0.000314	0.00525	CbGeAlD
Quetiapine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000312	0.00522	CbGeAlD
Quetiapine—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.00031	0.00519	CbGeAlD
Quetiapine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000307	0.00514	CbGeAlD
Quetiapine—HTR3A—brain—attention deficit hyperactivity disorder	0.000303	0.00507	CbGeAlD
Quetiapine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000302	0.00504	CbGeAlD
Quetiapine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000295	0.00494	CbGeAlD
Quetiapine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000295	0.00493	CbGeAlD
Quetiapine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00029	0.00485	CbGeAlD
Quetiapine—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000287	0.0048	CbGeAlD
Quetiapine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00027	0.00451	CbGeAlD
Quetiapine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000269	0.00449	CbGeAlD
Quetiapine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000269	0.00449	CbGeAlD
Quetiapine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00026	0.00434	CbGeAlD
Quetiapine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000259	0.00433	CbGeAlD
Quetiapine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000257	0.0043	CbGeAlD
Quetiapine—HTR1B—brain—attention deficit hyperactivity disorder	0.000255	0.00426	CbGeAlD
Quetiapine—CHRM2—brain—attention deficit hyperactivity disorder	0.000253	0.00423	CbGeAlD
Quetiapine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000253	0.00423	CbGeAlD
Quetiapine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000249	0.00417	CbGeAlD
Quetiapine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000248	0.00414	CbGeAlD
Quetiapine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000247	0.00414	CbGeAlD
Quetiapine—HTR1D—brain—attention deficit hyperactivity disorder	0.000246	0.00412	CbGeAlD
Quetiapine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000245	0.0352	CrCbGaD
Quetiapine—HTR2C—brain—attention deficit hyperactivity disorder	0.000244	0.00408	CbGeAlD
Quetiapine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000243	0.00406	CbGeAlD
Quetiapine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000242	0.00404	CbGeAlD
Quetiapine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000239	0.00399	CbGeAlD
Quetiapine—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000236	0.00395	CbGeAlD
Quetiapine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000234	0.00391	CbGeAlD
Quetiapine—Olanzapine—DRD5—attention deficit hyperactivity disorder	0.000233	0.0335	CrCbGaD
Quetiapine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000233	0.0039	CbGeAlD
Quetiapine—CHRM1—brain—attention deficit hyperactivity disorder	0.00023	0.00385	CbGeAlD
Quetiapine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000229	0.00383	CbGeAlD
Quetiapine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000229	0.00382	CbGeAlD
Quetiapine—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000227	0.0038	CbGeAlD
Quetiapine—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000222	0.00372	CbGeAlD
Quetiapine—Olanzapine—ADRA2C—attention deficit hyperactivity disorder	0.00022	0.0316	CrCbGaD
Quetiapine—CHRM3—brain—attention deficit hyperactivity disorder	0.000206	0.00345	CbGeAlD
Quetiapine—HTR1A—brain—attention deficit hyperactivity disorder	0.000205	0.00344	CbGeAlD
Quetiapine—HTR7—brain—attention deficit hyperactivity disorder	0.000196	0.00328	CbGeAlD
Quetiapine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000195	0.00326	CbGeAlD
Quetiapine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000193	0.00323	CbGeAlD
Quetiapine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000192	0.00321	CbGeAlD
Quetiapine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000189	0.00317	CbGeAlD
Quetiapine—Flupentixol—DRD1—attention deficit hyperactivity disorder	0.000189	0.0271	CrCbGaD
Quetiapine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000188	0.00315	CbGeAlD
Quetiapine—DRD2—brain—attention deficit hyperactivity disorder	0.000186	0.0031	CbGeAlD
Quetiapine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000185	0.00309	CbGeAlD
Quetiapine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000181	0.00303	CbGeAlD
Quetiapine—ADRA2C—brain—attention deficit hyperactivity disorder	0.00018	0.00302	CbGeAlD
Quetiapine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000177	0.00296	CbGeAlD
Quetiapine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000168	0.0241	CrCbGaD
Quetiapine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000163	0.00273	CbGeAlD
Quetiapine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.00016	0.00268	CbGeAlD
Quetiapine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000154	0.00258	CbGeAlD
Quetiapine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000151	0.00252	CbGeAlD
Quetiapine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000148	0.00248	CbGeAlD
Quetiapine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000148	0.0213	CrCbGaD
Quetiapine—HRH1—brain—attention deficit hyperactivity disorder	0.000147	0.00245	CbGeAlD
Quetiapine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000146	0.00244	CbGeAlD
Quetiapine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.000145	0.0209	CrCbGaD
Quetiapine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000144	0.00241	CbGeAlD
Quetiapine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000143	0.00239	CbGeAlD
Quetiapine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00014	0.00235	CbGeAlD
Quetiapine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.0198	CrCbGaD
Quetiapine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000137	0.0023	CbGeAlD
Quetiapine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.000137	0.0197	CrCbGaD
Quetiapine—Flupentixol—DRD2—attention deficit hyperactivity disorder	0.000133	0.0191	CrCbGaD
Quetiapine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000128	0.00214	CbGeAlD
Quetiapine—Clozapine—HRH3—attention deficit hyperactivity disorder	0.000126	0.0181	CrCbGaD
Quetiapine—HTR2A—brain—attention deficit hyperactivity disorder	0.000122	0.00205	CbGeAlD
Quetiapine—Olanzapine—DRD4—attention deficit hyperactivity disorder	0.000119	0.0172	CrCbGaD
Quetiapine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000118	0.017	CrCbGaD
Quetiapine—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.000115	0.0165	CrCbGaD
Quetiapine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000112	0.00187	CbGeAlD
Quetiapine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000106	0.0153	CrCbGaD
Quetiapine—Olanzapine—HTR1B—attention deficit hyperactivity disorder	0.000106	0.0152	CrCbGaD
Quetiapine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000105	0.00176	CbGeAlD
Quetiapine—Olanzapine—DRD3—attention deficit hyperactivity disorder	0.000103	0.0148	CrCbGaD
Quetiapine—Flupentixol—HTR2A—attention deficit hyperactivity disorder	0.000103	0.0148	CrCbGaD
Quetiapine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000101	0.00169	CbGeAlD
Quetiapine—Olanzapine—DRD1—attention deficit hyperactivity disorder	0.000101	0.0145	CrCbGaD
Quetiapine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	9.99e-05	0.0144	CrCbGaD
Quetiapine—ABCB1—cerebellum—attention deficit hyperactivity disorder	9.88e-05	0.00165	CbGeAlD
Quetiapine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	9.85e-05	0.0142	CrCbGaD
Quetiapine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	9.8e-05	0.0141	CrCbGaD
Quetiapine—Amoxapine—DRD4—attention deficit hyperactivity disorder	9.49e-05	0.0137	CrCbGaD
Quetiapine—Olanzapine—ADRA2A—attention deficit hyperactivity disorder	9.38e-05	0.0135	CrCbGaD
Quetiapine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	9.29e-05	0.0134	CrCbGaD
Quetiapine—Thiothixene—DRD1—attention deficit hyperactivity disorder	9.14e-05	0.0132	CrCbGaD
Quetiapine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	9.14e-05	0.0132	CrCbGaD
Quetiapine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	9.06e-05	0.013	CrCbGaD
Quetiapine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	8.9e-05	0.0128	CrCbGaD
Quetiapine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	8.49e-05	0.0122	CrCbGaD
Quetiapine—Amoxapine—HTR1B—attention deficit hyperactivity disorder	8.43e-05	0.0121	CrCbGaD
Quetiapine—Amoxapine—DRD3—attention deficit hyperactivity disorder	8.19e-05	0.0118	CrCbGaD
Quetiapine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	8.05e-05	0.0116	CrCbGaD
Quetiapine—Amoxapine—DRD1—attention deficit hyperactivity disorder	8.04e-05	0.0116	CrCbGaD
Quetiapine—ABCB1—brain—attention deficit hyperactivity disorder	8.02e-05	0.00134	CbGeAlD
Quetiapine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	7.9e-05	0.0114	CrCbGaD
Quetiapine—Amoxapine—SLC6A3—attention deficit hyperactivity disorder	7.62e-05	0.011	CrCbGaD
Quetiapine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	7.48e-05	0.0108	CrCbGaD
Quetiapine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	7.47e-05	0.0108	CrCbGaD
Quetiapine—Amoxapine—ADRA2A—attention deficit hyperactivity disorder	7.47e-05	0.0107	CrCbGaD
Quetiapine—Loxapine—DRD4—attention deficit hyperactivity disorder	7.42e-05	0.0107	CrCbGaD
Quetiapine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	7.34e-05	0.0106	CrCbGaD
Quetiapine—Olanzapine—DRD2—attention deficit hyperactivity disorder	7.12e-05	0.0102	CrCbGaD
Quetiapine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	6.91e-05	0.00995	CrCbGaD
Quetiapine—Promazine—DRD4—attention deficit hyperactivity disorder	6.65e-05	0.00957	CrCbGaD
Quetiapine—Loxapine—HTR1B—attention deficit hyperactivity disorder	6.59e-05	0.00948	CrCbGaD
Quetiapine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	6.55e-05	0.00942	CrCbGaD
Quetiapine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	6.44e-05	0.00927	CrCbGaD
Quetiapine—Thiothixene—DRD2—attention deficit hyperactivity disorder	6.44e-05	0.00927	CrCbGaD
Quetiapine—Loxapine—DRD3—attention deficit hyperactivity disorder	6.39e-05	0.0092	CrCbGaD
Quetiapine—Loxapine—DRD1—attention deficit hyperactivity disorder	6.28e-05	0.00903	CrCbGaD
Quetiapine—Perphenazine—DRD1—attention deficit hyperactivity disorder	6.25e-05	0.00899	CrCbGaD
Quetiapine—Clozapine—DRD4—attention deficit hyperactivity disorder	6.23e-05	0.00896	CrCbGaD
Quetiapine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	6.16e-05	0.00886	CrCbGaD
Quetiapine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	5.95e-05	0.00856	CrCbGaD
Quetiapine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	5.83e-05	0.00839	CrCbGaD
Quetiapine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	5.81e-05	0.00835	CrCbGaD
Quetiapine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	5.78e-05	0.00831	CrCbGaD
Quetiapine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	5.74e-05	0.00826	CrCbGaD
Quetiapine—Amoxapine—SLC6A4—attention deficit hyperactivity disorder	5.7e-05	0.0082	CrCbGaD
Quetiapine—Amoxapine—DRD2—attention deficit hyperactivity disorder	5.67e-05	0.00815	CrCbGaD
Quetiapine—Promazine—DRD1—attention deficit hyperactivity disorder	5.63e-05	0.0081	CrCbGaD
Quetiapine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	5.57e-05	0.00801	CrCbGaD
Quetiapine—Clozapine—HTR1B—attention deficit hyperactivity disorder	5.53e-05	0.00796	CrCbGaD
Quetiapine—Olanzapine—HTR2A—attention deficit hyperactivity disorder	5.5e-05	0.00791	CrCbGaD
Quetiapine—Clozapine—DRD3—attention deficit hyperactivity disorder	5.37e-05	0.00772	CrCbGaD
Quetiapine—Trazodone—HTR2A—attention deficit hyperactivity disorder	5.31e-05	0.00765	CrCbGaD
Quetiapine—Clozapine—DRD1—attention deficit hyperactivity disorder	5.27e-05	0.00758	CrCbGaD
Quetiapine—Promazine—ADRA2A—attention deficit hyperactivity disorder	5.23e-05	0.00753	CrCbGaD
Quetiapine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	5.06e-05	0.00728	CrCbGaD
Quetiapine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	4.98e-05	0.00716	CrCbGaD
Quetiapine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	4.98e-05	0.00716	CrCbGaD
Quetiapine—Clozapine—ADRA2A—attention deficit hyperactivity disorder	4.9e-05	0.00704	CrCbGaD
Quetiapine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	4.45e-05	0.00641	CrCbGaD
Quetiapine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	4.45e-05	0.0064	CrCbGaD
Quetiapine—Loxapine—DRD2—attention deficit hyperactivity disorder	4.42e-05	0.00637	CrCbGaD
Quetiapine—Perphenazine—DRD2—attention deficit hyperactivity disorder	4.4e-05	0.00634	CrCbGaD
Quetiapine—Amoxapine—HTR2A—attention deficit hyperactivity disorder	4.38e-05	0.0063	CrCbGaD
Quetiapine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	4.3e-05	0.00619	CrCbGaD
Quetiapine—Promazine—DRD2—attention deficit hyperactivity disorder	3.97e-05	0.00571	CrCbGaD
Quetiapine—Clozapine—DRD2—attention deficit hyperactivity disorder	3.72e-05	0.00534	CrCbGaD
Quetiapine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	3.44e-05	0.00495	CrCbGaD
Quetiapine—Loxapine—HTR2A—attention deficit hyperactivity disorder	3.42e-05	0.00492	CrCbGaD
Quetiapine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	3.4e-05	0.0049	CrCbGaD
Quetiapine—Promazine—HTR2A—attention deficit hyperactivity disorder	3.07e-05	0.00441	CrCbGaD
Quetiapine—Clozapine—HTR2A—attention deficit hyperactivity disorder	2.87e-05	0.00413	CrCbGaD
Quetiapine—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.38e-06	3.99e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.37e-06	3.99e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.37e-06	3.99e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.33e-06	3.96e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.31e-06	3.95e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.29e-06	3.94e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	6.28e-06	3.93e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.25e-06	3.91e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.23e-06	3.9e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.23e-06	3.9e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.23e-06	3.9e-05	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.21e-06	3.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.18e-06	3.87e-05	CbGpPWpGaD
Quetiapine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	6.17e-06	3.86e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.16e-06	3.86e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.15e-06	3.85e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.12e-06	3.83e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.06e-06	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.05e-06	3.79e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.04e-06	3.78e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.03e-06	3.77e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.01e-06	3.76e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.01e-06	3.76e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.98e-06	3.75e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.94e-06	3.72e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.93e-06	3.71e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.93e-06	3.71e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.92e-06	3.7e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.87e-06	3.67e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.86e-06	3.67e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.86e-06	3.67e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	5.85e-06	3.66e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.85e-06	3.66e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.84e-06	3.66e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.84e-06	3.66e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.84e-06	3.66e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.83e-06	3.65e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.81e-06	3.64e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.81e-06	3.64e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.78e-06	3.62e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.76e-06	3.61e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	5.76e-06	3.6e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.74e-06	3.6e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.73e-06	3.58e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.67e-06	3.55e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.65e-06	3.54e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.65e-06	3.54e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.64e-06	3.53e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.63e-06	3.52e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.61e-06	3.51e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.56e-06	3.48e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.56e-06	3.48e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.53e-06	3.46e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.46e-06	3.42e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.46e-06	3.42e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.46e-06	3.42e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.45e-06	3.41e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.45e-06	3.41e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.43e-06	3.4e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.4e-06	3.38e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	5.39e-06	3.38e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.37e-06	3.36e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.36e-06	3.35e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.35e-06	3.35e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.35e-06	3.35e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.34e-06	3.34e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.32e-06	3.33e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.3e-06	3.32e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.29e-06	3.31e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.27e-06	3.3e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.26e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.26e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.25e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.25e-06	3.29e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.23e-06	3.28e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.17e-06	3.24e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.17e-06	3.24e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.14e-06	3.22e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.13e-06	3.21e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.11e-06	3.2e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.11e-06	3.2e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.09e-06	3.19e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.08e-06	3.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.05e-06	3.16e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	5.04e-06	3.15e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.04e-06	3.15e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.02e-06	3.14e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.01e-06	3.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5e-06	3.13e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5e-06	3.13e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.96e-06	3.1e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.95e-06	3.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.94e-06	3.09e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.94e-06	3.09e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.93e-06	3.09e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.92e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	4.91e-06	3.07e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.88e-06	3.06e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	4.87e-06	3.05e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.86e-06	3.05e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.86e-06	3.04e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.85e-06	3.03e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.83e-06	3.02e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.78e-06	3e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.77e-06	2.99e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.77e-06	2.99e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	4.76e-06	2.98e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.76e-06	2.98e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.73e-06	2.96e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	4.73e-06	2.96e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.69e-06	2.94e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.68e-06	2.93e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.68e-06	2.93e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.67e-06	2.92e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.65e-06	2.91e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.62e-06	2.89e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.61e-06	2.88e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.6e-06	2.88e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.6e-06	2.88e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.59e-06	2.88e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.54e-06	2.85e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.54e-06	2.84e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.54e-06	2.84e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.53e-06	2.84e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.52e-06	2.83e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	4.52e-06	2.83e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.52e-06	2.83e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.51e-06	2.82e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.5e-06	2.82e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.5e-06	2.82e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.48e-06	2.81e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.47e-06	2.8e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.47e-06	2.8e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.46e-06	2.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.46e-06	2.79e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.45e-06	2.79e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	4.45e-06	2.79e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.45e-06	2.79e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.44e-06	2.78e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.43e-06	2.78e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.43e-06	2.77e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.42e-06	2.76e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.42e-06	2.76e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.41e-06	2.76e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.4e-06	2.76e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.39e-06	2.75e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.39e-06	2.75e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.37e-06	2.74e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.37e-06	2.74e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.37e-06	2.74e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.34e-06	2.72e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.33e-06	2.71e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.32e-06	2.7e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.3e-06	2.69e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.27e-06	2.67e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.25e-06	2.66e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	4.22e-06	2.64e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	4.19e-06	2.62e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	4.16e-06	2.61e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.16e-06	2.61e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.14e-06	2.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.13e-06	2.59e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.11e-06	2.57e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.1e-06	2.57e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	4.09e-06	2.56e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	4.09e-06	2.56e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.09e-06	2.56e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.08e-06	2.55e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.07e-06	2.55e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.04e-06	2.53e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.04e-06	2.53e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.02e-06	2.52e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.01e-06	2.51e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.94e-06	2.47e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.88e-06	2.43e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	3.87e-06	2.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	3.84e-06	2.41e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.82e-06	2.39e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.82e-06	2.39e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.81e-06	2.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.74e-06	2.34e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.62e-06	2.26e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	3.55e-06	2.22e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.53e-06	2.21e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	3.52e-06	2.2e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.49e-06	2.19e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.45e-06	2.16e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.44e-06	2.16e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.36e-06	2.1e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.33e-06	2.09e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.33e-06	2.08e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.32e-06	2.08e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.22e-06	2.02e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.17e-06	1.99e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.17e-06	1.98e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.09e-06	1.93e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.93e-06	1.83e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.87e-06	1.8e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.86e-06	1.79e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.85e-06	1.79e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.83e-06	1.77e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.82e-06	1.76e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	2.74e-06	1.72e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	2.72e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.72e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	2.72e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	2.68e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	2.68e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.66e-06	1.66e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.64e-06	1.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.62e-06	1.64e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	2.52e-06	1.58e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	2.5e-06	1.57e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.49e-06	1.56e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.38e-06	1.49e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.38e-06	1.49e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.37e-06	1.48e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.32e-06	1.45e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.28e-06	1.43e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.25e-06	1.41e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.18e-06	1.36e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.15e-06	1.35e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	2.1e-06	1.32e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.07e-06	1.3e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.05e-06	1.29e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	2.04e-06	1.28e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.03e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.03e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.83e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	1.81e-06	1.13e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.77e-06	1.11e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.76e-06	1.1e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.71e-06	1.07e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.68e-06	1.05e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	1.66e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.65e-06	1.03e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.64e-06	1.02e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.55e-06	9.7e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.53e-06	9.55e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.52e-06	9.53e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	1.52e-06	9.52e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.52e-06	9.5e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.51e-06	9.47e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.5e-06	9.38e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.49e-06	9.35e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.39e-06	8.69e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	1.18e-06	7.36e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	1.15e-06	7.18e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.08e-06	6.77e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	7.07e-07	4.43e-06	CbGpPWpGaD
